This content was archived on March 14, 2017.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Timely, comprehensive and reliable public notification of drug shortages and discontinuances provides the healthcare system with the time and information needed to minimise disruptions on drug supply and patient care. The Public Notification Register is intended to be an interim measure to enhance industry accountability and transparency for the voluntary public notification of shortages on the industry-run Canadian Drug Shortage Website while mandatory drug shortage reporting regulations are put into place. For more information on drug shortage notification, please visit the Information on Drug Shortages section on the Health Canada Website.
Health Canada has asked all companies in Canada authorized to sell human pharmaceutical or biologic drug products (Drug Identification Number owners) to make a commitment to public notification of drug shortages and discontinuances on the industry-run Canadian Drug Shortage Website. Company commitments are made public on the Public Notification Register.
The scope of the Public Notification Register is limited to disruptions of human drugs and does not apply to veterinary drugs. It is not the focus of the Public Notification Register to address supply disruptions of consumer health products, personal-care products, cosmetic-like drugs, toiletries or disinfectants.
For those suppliers that have not yet provided their commitment to notification on the Canadian Drug Shortage Website, they are encouraged to send confirmation of their commitment in an e-mail to email@example.com. Once processed, Health Canada will add their company's name to the Register.